Koch Disruptive Technologies helped molecular diagnostics system developer Sense Biodetection expand its latest round to $65m while Hilti bought portfolio company Fieldwire for $300m.

The Legend Capital-backed endoscope provider has gone public on the Shanghai Stock Exchange’s Star market.

The DRx Capital-backed healthcare database developer scored fresh capital to increase its overall funding to over $190m.

The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.

The neuromodulation device maker increased its overall funding to $145m in a round led by Ascension Ventures.

Sinopharm, Sinovac Biotech and Gan & Lee Pharmaceuticals all took part in the liquid chromatography technology provider’s series D round.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.

Olympus Innovation Ventures will provide funding for early and growth-stage medical technology developers.

NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.

Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.